| Dr Jennifer Alissa Moliterno Gunel, MD | |
|
333 Cedar St, Tmp 403, New Haven, CT 06510-3206 | |
| (203) 785-2791 | |
| (203) 785-2042 |
| Full Name | Dr Jennifer Alissa Moliterno Gunel |
|---|---|
| Gender | Female |
| Speciality | Neurosurgery |
| Experience | 19 Years |
| Location | 333 Cedar St, New Haven, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205010261 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 52251 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Yale-new Haven Hospital | New haven, CT | Hospital |
| Bridgeport Hospital | Bridgeport, CT | Hospital |
| Greenwich Hospital Association - | Greenwich, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rehabilitation Associates Inc | 8022905322 | 297 |
| Yale University | 9436061736 | 2241 |
News Archive
Myriad Genetics, Inc. announced today that it has signed an expanded companion diagnostic agreement with AbbVie, Inc., a leading global biopharmaceutical company to use Tumor BRACAnalysis CDx™ as a companion diagnostic in support of AbbVie's novel poly (ADP-ribose) polymerase or PARP inhibitor, veliparib.
Oncology pharmacy practitioners around the globe are fighting to provide cancer patients high quality cancer care with increasingly limited and sometimes restricted personal protective equipment supply as well as impaired access to essential anticancer medication, according to University of California, Irvine-led study.
A report from researchers at Children's Hospital Boston and the Harvard Stem Cell Institute sheds new light on a now-discredited Korean embryonic stem cell line, setting the historical record straight and also establishing a much-needed set of standards for characterizing human embryonic stem cells.
Scientists at Eli Lilly say the first human trial of a new schizophrenia drug shows promise for sufferers of the debilitating mental illness.
Parkinson disease (PD) is caused by the progressive degeneration of brain cells known as dopamine (DA) cells.
› Verified 1 days ago
| Entity Name | Yale University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205822236 PECOS PAC ID: 9436061736 Enrollment ID: O20031105000015 |
News Archive
Myriad Genetics, Inc. announced today that it has signed an expanded companion diagnostic agreement with AbbVie, Inc., a leading global biopharmaceutical company to use Tumor BRACAnalysis CDx™ as a companion diagnostic in support of AbbVie's novel poly (ADP-ribose) polymerase or PARP inhibitor, veliparib.
Oncology pharmacy practitioners around the globe are fighting to provide cancer patients high quality cancer care with increasingly limited and sometimes restricted personal protective equipment supply as well as impaired access to essential anticancer medication, according to University of California, Irvine-led study.
A report from researchers at Children's Hospital Boston and the Harvard Stem Cell Institute sheds new light on a now-discredited Korean embryonic stem cell line, setting the historical record straight and also establishing a much-needed set of standards for characterizing human embryonic stem cells.
Scientists at Eli Lilly say the first human trial of a new schizophrenia drug shows promise for sufferers of the debilitating mental illness.
Parkinson disease (PD) is caused by the progressive degeneration of brain cells known as dopamine (DA) cells.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jennifer Alissa Moliterno Gunel, MD 333 Cedar St # 410, New Haven, CT 06510-3206 Ph: (203) 785-2791 | Dr Jennifer Alissa Moliterno Gunel, MD 333 Cedar St, Tmp 403, New Haven, CT 06510-3206 Ph: (203) 785-2791 |
News Archive
Myriad Genetics, Inc. announced today that it has signed an expanded companion diagnostic agreement with AbbVie, Inc., a leading global biopharmaceutical company to use Tumor BRACAnalysis CDx™ as a companion diagnostic in support of AbbVie's novel poly (ADP-ribose) polymerase or PARP inhibitor, veliparib.
Oncology pharmacy practitioners around the globe are fighting to provide cancer patients high quality cancer care with increasingly limited and sometimes restricted personal protective equipment supply as well as impaired access to essential anticancer medication, according to University of California, Irvine-led study.
A report from researchers at Children's Hospital Boston and the Harvard Stem Cell Institute sheds new light on a now-discredited Korean embryonic stem cell line, setting the historical record straight and also establishing a much-needed set of standards for characterizing human embryonic stem cells.
Scientists at Eli Lilly say the first human trial of a new schizophrenia drug shows promise for sufferers of the debilitating mental illness.
Parkinson disease (PD) is caused by the progressive degeneration of brain cells known as dopamine (DA) cells.
› Verified 1 days ago
Dr. Charles Christian Matouk, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 800 Howard Ave, Lower Level, Neuroscience Center, New Haven, CT 06519 Phone: 203-737-2096 Fax: 203-785-2044 | |
Dr. Kevin Ray, D.O. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 20 York St, New Haven, CT 06510 Phone: 203-737-7000 | |
Murat Gunel, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 800 Howard Ave, Yale Physicians Building - 3rd Floor, New Haven, CT 06519 Phone: 203-785-2805 Fax: 203-785-6916 | |
Veronica L Chiang, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 800 Howard Ave, Yale Physicians Bldg, New Haven, CT 06519 Phone: 203-785-2805 Fax: 203-785-6916 | |
Dr. Farhad F Bahrassa, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 333 Cedar St, New Haven, CT 06510 Phone: 203-785-2807 | |
Pedro De Oliveira Coutinho, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 20 York St, New Haven, CT 06510 Phone: 203-688-4242 | |
Mihir Gupta, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 20 York St, New Haven, CT 06510 Phone: 203-688-4242 |